Effects of pre-transplant L-carnitine supplementation on primary graft dysfunction in liver transplant recipients: a pilot, randomized, placebo-controlled clinical trial

Primary graft dysfunction (PGD) and non-function (PNF) happen in 8.7-24.7% and 0.9-7.2% of liver transplant recipients, respectively. These phenomena increase treatment cost and patients’ death. This study assessed the effect of L-carnitine supplementation on the incidences of PNF/PGD in liver trans...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Res Pharm Sci
Asıl Yazarlar: Khajeh, Behrouz, Dashti-Khavidaki, Simin, Nasiri-Toosi, Mohsen, Mohammadi, Keyhan, Jafari, Atefeh
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wolters Kluwer - Medknow 2019
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6937745/
https://ncbi.nlm.nih.gov/pubmed/32038730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1735-5362.272537
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller